Grant: PROGENICS PHARMACEUTICALS, INC.
PROGENICS PHARMACEUTICALS, INC.
CDFA Program Title
Trans-NIH Recovery Act Research Support
Award Title:-? Novel, Non-antibiotic Therapy for Clostridium difficile-Associated Disease Award Description: Clostridium difficile is a spore-forming bacterium that is the leading cause of hospital acquired diarrhea and is responsible for more deaths per
Vendors Connected to Award
|TRUSTEES OF TUFTS COLLEGE INC||Primary vendor||$170,306.00|
|BOARD OF REGENTS OF THE UNIVERSITY OF WISCONS||Primary vendor||$68,491.00|
|Ricerca Biosciences, LLC||Primary vendor||$79,650.00|